Drug intelligence / Profile preview

N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule with the chemical formula C20H19ClN4O5 and a molecular weight of approximately 430.85 g/mol[4][7]. It belongs to the class of pyrimidinediamines and features both a benzodioxole and a trimethoxyphenyl moiety. While structurally related compounds in this series have been developed as potent inhibitors of tyrosine kinases (notably c-Src and Abl), there is no direct evidence that this specific compound has been advanced into clinical development or assigned a code name by pharmaceutical companies[1][3][7]. Its mechanism likely involves kinase inhibition due to its structural similarity to known Src/Abl inhibitors.

Other names
N~4~-(5-chloro-1,3-benzodioxol-4-yl)-N~2~-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine2,4-pyrimidinediamine N~4~-(5-chloro-1,3-benzodioxol-4 yl)-N~2~-(3 45 trimethoxyphenyl)
02

Targets

EPHB4 (Ephrin type-B receptor 4)

Beyond the preview

Go deeper on N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call